Oral docetaxel plus encequidar – A pharmacokinetic model and evaluation against IV docetaxel
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Oral docetaxel plus encequidar – A pharmacokinetic model and evaluation against IV docetaxel ; volume:51 ; number:4 ; day:19 ; month:3 ; year:2024 ; pages:335-352 ; date:8.2024
Journal of pharmacokinetics and pharmacodynamics ; 51, Heft 4 (19.3.2024), 335-352, 8.2024
- Creator
-
Wang, David
Jackson, Chris
Hung, Noelyn
Hung, Tak
Kwan, Rudolf
Chan, Wing-Kai
Qin, Albert
Hughes-Medlicott, Natalie J.
Glue, Paul
Duffull, Stephen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10928-024-09913-y
- URN
-
urn:nbn:de:101:1-2410080926054.563586921111
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, David
- Jackson, Chris
- Hung, Noelyn
- Hung, Tak
- Kwan, Rudolf
- Chan, Wing-Kai
- Qin, Albert
- Hughes-Medlicott, Natalie J.
- Glue, Paul
- Duffull, Stephen
- SpringerLink (Online service)
Other Objects (12)
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota
Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Severe Photo Toxicity Recalled by Docetaxel
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
Novel Docetaxel-Loaded Micelles Based on all-trans-Retinoic Acid: Preparation and Pharmacokinetic Study in Rats
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Kastrationsresistentes Prostatakarzinom unter Docetaxel : eine pharmakoökonomische Studie
Docetaxel enhances lysosomal function through TFEB activation
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota
Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Severe Photo Toxicity Recalled by Docetaxel
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
Novel Docetaxel-Loaded Micelles Based on all-trans-Retinoic Acid: Preparation and Pharmacokinetic Study in Rats
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Kastrationsresistentes Prostatakarzinom unter Docetaxel : eine pharmakoökonomische Studie
Docetaxel enhances lysosomal function through TFEB activation
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota
Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Severe Photo Toxicity Recalled by Docetaxel
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
Novel Docetaxel-Loaded Micelles Based on all-trans-Retinoic Acid: Preparation and Pharmacokinetic Study in Rats
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Kastrationsresistentes Prostatakarzinom unter Docetaxel : eine pharmakoökonomische Studie